{
    "datasets": {
        "A24722": {
            "analysis_attributes": {
                "description_url": "http://www.epigenomes.ca/methods.html"
            },
            "analysis_group": "CEMT",
            "browser": {
                "copy_number_variation": {
                    "big_data_url": "http://www.epigenomes.ca/data/CEMT/CEMT_7/CNV/A24722.CEMT_7.A24722_3_lanes_dupsFlagged.bam_ratio.freec.bw",
                    "description_url": "http://www.epigenomes.ca/methods.html"
                }
            },
            "experiment": "WGS",
            "experiment_attributes": {
                "experiment_type": "WGS"
            },
            "sample_attributes": {
                "batch": "1",
                "biomaterial_provider": "Aparicio",
                "biomaterial_type": "Cell Line",
                "differentiation_method": "NA",
                "differentiation_stage": "NA",
                "disease": "Mammary gland-Breast Fibrocystic Disease",
                "epirr_id": "IHECRE00000001.2",
                "ihec_reference_epigenome_identifier": "IHECRE00000001.2",
                "line": "MCF10A",
                "lineage": "mammary gland epithelia",
                "medium": "Growth media: DMEM/F12 +5% horse serum (it also includes FGF (20 ug/ml), Hydrocortizone (0.5 mg/ml), Cholera Toxin (10 ug/ml), insulin (1 mg/ml), Pen/Strep 1%)",
                "molecule": "genomic DNA",
                "passage": "3",
                "sample_id": "CEMT0007",
                "sample_ontology_uri": "EFO : EFO_0001200",
                "sex": "Female"
            }
        }
    },
    "hub_description": {
        "assembly": "hg19",
        "email": "edcc@bcgsc.ca",
        "publishing_group": "CEMT",
        "taxon_id": 9606
    }
}